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Centrifugation and capillarity integrated
into a multiple analyte whole blood analyser
C. T. Schembri, T. L. Burd, A. R. Kopf-Sill,
L. R. Shea, and B. Braynin
Abaxis, 1320 Chesapeake Terrace, Sunnyvale, California 94089, USA
A unique clinical chemistry analyser is described which processes
90 t2l of whole blood (fingerstick or venous) into multiple aliquots
of diluted plasma and reports the results of 12 tests in 14 min. To
perform a panel of tests, the operator applies the unmetered sample
directly into a single use, 8 cm diameter plastic rotor which contains
the required liquid diluent and dry reagents. Using centrifugal and
capillary forces, the rotor meters the required amount of blood,
separates the red cells, meters the plasma, meters the diluent, mixes
lhe fluidf, distributes the fluid to the reaction cuvettes and mixes
the reagents and the dilutedplasma in the cuvettes. The instrument
monitors the reagent reactions simultaneously using nine wave-
lengths, calculates the resultsfrom the absorbance data, and reports
the results.
Introduction
Rapid availablity of in vitro diagnostic results is advan-
tageous to both the physician and the patient. An illness
can be diagnosed more quickly and costs due to the illness
can be decreased [1]. Turnaround times are shortened,
which reduces the likelihood that test results are no longer
valid by the time they are received by the physician [2].
Errors inherent in the laboratory testing cycle are also
minimized by performing tests near the patient. Elimin-
ating the need to transport samples to a central laboratory
reduces such problems as misplaced samples, inaccurate
labeling and transcription, improper icing and bagging,
and sample degradation [1, 3, 4].
Test systems must produce reliable results, independent
of the user’s skill, as well as shorten turnaround time and
eliminate several sample handling steps [5]. An important
criterion is ease of use, siaace it has been demonstrated
that medical office personnel can produce reliable results
when using systems with simple protocols [6]. Test systems
using whole blood and requiring no pipetting or diluting
steps are also more accurate than systems which require
specimen manipulation steps [1].
This paper reports on a near-patient, portable, clinical
chemistry system that provides the clinician with rapid
availability ofin vitro diagnostic results. The Piccolo system
reports results for panels of blood tests within 14 min of
sample application to the consumable. The system consists
of the single-use reagent rotor and the Piccolo analyser.
An operator applies a few drops of capillary or venous
whole blood to the reagent rotor and places it into the
analyser. Using capillary action and centrifugal force
acting from the centre of the rotor, the system completes
all sample processing and optically analyses the cuvettes
t)r multiple chemistries simultaneously. The panel of
results is printed on an adhesive-backed card for easy
application to patient charts. The design of this system,
with emphasis on the consumable, which converts the
unmetered blood sample into multiple aliquots ofprecisely
diluted plasma, is described here.
Materials and methods
The reagent rotor
The reagent rotor is an 8 cm diameter consumable
containing all the required diluent and dry reagents to
perform a panel of tests. Three injection-molded plastic
parts are ultrasonically welded together to tbrm the
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Figure 1. Exploded view of the reagent rotor showing the rotor
base, diluent container, rotor cover, and bar code ring.
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Figure 2. Schemalic diagram q/" the rotor showing the sample in
application chamber.
Figure 4. Schematic diagram oj’the rotor showing blood enlering
lhe plasma melering chamber and diluenl being releasedfrom
Figure 3. Placing lhe rolor bzlo lhe inslrumenl.
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Figure 5. Schematic diagram of the rotor showing the plasma
metering chamber ,filled and the diluent metered and the system
cuvettes filling.
Figure 7. Schematic diagram of the rotor showing the mixing oj
the plasma and diluent.
Figure 6. Schematic diagram of the rotor showing the separation
completed and two siphons primed.
Figure 8. Schematic diagram of the rotor showing the distribution
of diluted plasma to the cuvettes containing reagents.
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reagent rotor. The base and middle layer are molded
fiom polymethylmethacrylate plastic and the top layer is
molded from ABS (acrylonitrile, butadiene and styrene)
plastic. The welded base and middle layers form the
cuvettes, chambers and passageways which allow the
fluids to be processed. The top layer protects the cuvette
windows i)om fingerprints, prevents contamination of the
analyser by any sample spilled on the rotor surface, and
provides imprinted bar-coded, rotor-specific calibration
information to the analyser. A sealed container in the
centre of the rotor contains 475 gl of diluent. Fluid loss
from this container is less than 5 gl per year when stored
at 8C (see figure 1).
The rotor contains 21 cuvettes that will be filled with
diluted plasma and four cuvettes that will be filled with
diluent. The cuvettes have five pathlengths (1"7 mm,
2"1 mm, 3"1 mm, 4"3 mm and 5"0 mm) to accommodate
different reagent sensitivities and analyte concentra-
tions. Premeasured, lyophilized reagent beads for each
chemistry in the panel are placed in the cuvettes at the
time of manufacture.
The analyser
The analyser is a portable spectrophotometer measuring
24 cm high by 15 cm wide by 30 cm deep; it weighs 6’4 kg.
A rotor drawer extending f?om the front of the analyser
positions the rotor on the centre of" the spindle at the
beginning of each run. The analyser’s motor and
controller drive the rotor through the profile of rotational
speeds needed to process the sample.
The optical system consists of a xenon arc stroboscopic
lamp and a beam-splitter/detector capable ofreading nine
wavelengths. A 16-bit analogue-to-digital converter is
used in signal processing. Two microprocessors control
the functions of the analyser. A heater maintains the rotor
at 37 _-+- IC during the reaction portion of the analysis.
The process
To perfbrm an analysis, the operator obtains a whole
blood sample from either a fingerstick or venipuncture.
Whole blood samples obtained by venipuncuture can be
analysed within 60min of collection and fingerstick
samples should be analysed immediately. A fiw drops of
sample are dispensed, via a microcapillary or other
transfir device, into the rotor sample port. Capillary
action draws the sample into the rotor. Sufficient sample
is applied to the rotor when the leading meniscus of the
sample creates a line between two arrows printed on the
rotor. The operator need not meter the sample prior to
application. A minimum of 90 gl of sample is required
and up to 120 gl may be applied to the rotor (see figure 2).
The operator places the rotor with applied sample in the
analyser drawer. The drawer closes and the analyser .auto-
matically centres the rotor on the spindle. The operator
inputs a patient identification number, starts the analysis,
and places a results card in the printer. The rotor is now
completely controlled by the analyser and no further
involvement from the operator is required (see figure 3).
Transparent to the user, the diluent container is opened
as the rotor is loaded onto the spindle. The diluent
container, a molded high-density polyethylene plastic
container, is sealed with polyethylene-laminated alumi-
num foil. A tab on the foil is folded back across the top
of the diluent container and heat staked to the rotor base.
A central post on the spindle enters the rotor and pushes
the diluent container up. This causes the foil to peel back
from the edge and create an opening to release the diluent.
The sample and diluent begin the processing on separate,
but parallel, pathways. At the start of analysis, the
analyser accelerates the rotor to 5000 r.p.m, counter-
clockwise and holds this speed for 2"5 min. Centrithgal
force causes the diluent to be thrown from the diluent
container into a holding chamber. The small exit channel
at the most radially outward point of the chamber allows
the diluent to fill a metering chamber in a controlled
manner. The chamber is filled completely with 356"25 gl
of diluent. The remaining diluent overflows this chamber
and moves through a channel which sequentially fills four
cuvettes and places the remaining diluent into a dump
isolated from the rest of the rotor. The four cuvettes are
used for internal rotor quality control.
Simultaneously with diluent metering, centrifugal forces
causes the sample to exit the application chamber and
move through a small channel into the plasma metering
chamber. The chamber is filled completely by 75 gl of
sample and the remainder overflows into a ’sufficient
sample’ cuvette. Any excess sample is trapped in an
isolation dump. If no fluid is detected in the ’sufficient
sample’ cuvette, the analysis is aborted due to a deficient
quantity ofsample. The precise quantity ofblood metered
into the plasma metering chamber is separated by
centrifugal force into plasma and red blood cells.
Adequate separation is achieved in 30 for most samples.
Samples with higher haematocrits require longer separa-
tion and packing times to provide the necessary 20 gl of
clear plasma. Spinning the rotor for 2"5 min is sufficient to
separate samples up to a haematocrit of62%. (See figures
4 and 5.)
The next step combines the diluent and plasma. A siphon
entrance of Capillary dimension, is located at the radially
outermost point ofthe diluent metering chamber. Another
siphon entrance is located partway down the plasma
metering chamber. Neither of these siphons fills during
the first spin because the centrifhgal force is fhr higher
than the capillary force. After the separation step is
completed, the rotor stops spinning and capillary forces
pull the fluids over the bend in the siphons. Both siphons
exit into a single mixing chamber (see figure 6).
The rotor is now spun at 5000 r.p.m, clockwise. The
diluent metering chamber is completely emptied since the
exit of the siphon is further from the center of" the rotor
than the extreme edge of the diluent metering chamber.
The plasma metering chamber is emptied to a radial
distance equaling the placement of the exit of the plasma
metering siphon. The volume of plasma metered is
18"75 gl. The remaining 56"25 t,tl ofsample and red blood
cells is trapped in the lower portion ofthe plasma metering
chamber.
The rotor speed is varied to mix the metered diluent and
plasma in the mixing chamber. The rotor abruptly brakes
to a speed of 750 r.p.m, and then slowly climbs back to
102C. T. Schembri el al. Centrifugation and capillarity integrated into a multiple analyte whole blood analyser
4000 r.p.m., this pattern is repeated for 15 cycles. The
abrupt deceleration provides sufficient tangential force to
move and mix the fluid in the mixing chamber. A
minimum speed of 750r.p.m. is required during the
mixing process, to ensure that the applied centrifugal force
exceeds the capillary strength of final siphon. This mixing
profile prevents priming of the siphon until the fluids are
homogeneously mixed (see figure 7).
The final siphon is primed by capillary action after mixing
is complete and the rotor is stopped. The rotor is then
span at 3000 r.p.m, clockwise for 40 s. The diluted plasma
flows out of the mixing chamber and into a distribution
channel which leads to 21 cuvettes and an isolation dump.
The 21 cuvettes are filled sequentially and the remaining
diluted plasma flows into the dump (see figure 8).
Each cuvette has a single channel for both flow of fluid
into the cuvette and air venting. Under highly controlled
conditions, the fluid flows down one side of the inlet
channel while air vents tiom the other side. No special
ligatures ofthe cuvette inlet channel are required to achieve
this control. The size of the fluid stream is controlled by
the resistance of the siphon, the rotational speed of the
rotor, and the pres.sure head of the remaining fluid. The
rotor must also spin fast enough to overcome the capillary
strength of the inlet channel which is 0"50 mm wide and
0" 13 mm high. Each cuvette contains one or two beads of
lyophilized reagents appropriate for the particular test to
be run within that cuvette; these beads dissolve completely
in the time required to fill the cuvette. Figure 9. Resulls card is prinled.
After all of the cuvettes are filled, and the excess diluted
plasma is isolated in the dump, the rotor is oscillated from
1000 r.p.m, clockwise to 1000 r.p.m, counterclockwise for
70 s. This oscillation cycle creates swirl patterns in the
cuvettes which mix the chemistry and the diluted plasma.
The spectrophotometer monitors the reactions in all of
the cuvettes tbr 3"5 min by flashing the xenon arc lamp
synchronously with the spinning rotor. The lamp is flashed
approximately 5000 times for each rotor.
Reproducibility of cuvette palhlength
The pathlength of all 25 cuvettes was measured on 82
ultrasonically welded rotors. The 82 rotors include
examples welded on two different welders, on different
days and from different lots of molded rotors. The
coefficient of variation (CV) of the most precise cuvette
was 0"07 and the least precise cuvette was 0"47.
The analyser detects the presence of each cuvette by
sensing 45 wedges of plastic placed every 12 around the
periphery of the rotor. On each spin, the processor selects
which cuvette to flash and which of the nine wavelengths
to measure.
The results are calculated and printed on an adhesive-
backed card for easy attachment to the patient’s files (see
figure 9). In addition, the results can be uploaded to a
computer via an RS-232 port.
Results
The rolor
The rotor’s contribution to total system imprecision is in
the reproducibility of cuvette pathlength between rotors;
and the precision of metering plasma and diluent and
homogeneously mixing the two fluids.
Precision offluid metering and mixing
The goal for precision of metering plasma and diluent
and mixing them homogeneously was2 or better. The
precision of the entire system was measured to obtain an
indication of the precision of the rotor’s fluid functions,
since the contribution of error from the pathlength and
the analyser was minimal. Within-day system precision
was obtained using the glucose method and plasma. Four
rotors were run on eight analysers for a total sample size
of 32. The mean was 115 mg/dl (6"4 mmol/1) and the CV
was 1"0. Plasma was used as the sample to ensure that
the glucose value would be stable for the duration of the
study.
The contributions to error in this measurement include:
plasma metering; diluent metering; mixing homogeneity;
pathlength of the reagent and sample blank cuvettes;
reagent imprecision; instrument-to-instrument variation;
instrument noise; and changes within the controls run on
the analyser.
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Table 1. Day-to-@ reproducibility investigation. Table 2. Total imprecision.
Chemistry Replicates Mean CV Chemistry
Glucose--normal 120 70 mg/dl 1"0% Glucose--normal
(3"9 mmol/1)
Glucose--abnormal 120 260 mg/dl 1"6% Glucose--abnormal
(14"4 mmol/1)
AST--normal 120 40 U/1 3"2
AST--abnormal 120 150 U/1 1"7
Uric acid--normal 120 3"7 mg/dl 6"3
,(0"22 mmol/1)
Uric acid--abnormal 120 7"6 mg/dl 3"
(0"46 mmol/1)
Total bilirubin--normal 120
Total bilirubin--abnormal 120
120 Total protein--normal
1"0 mg/dl 7"5
(17"1 gmol/1)
5"6 mg/dl 5"0
(95"8 gmol/1)
6.6 g/dl 1.3%
(66 g/l)
4.6 g/dl 2"3%
(46 g/I)
Total protein--abnormal 120
Replicates Mean
80 75 mg/dl
(4"2 mmol/1)
80 261 mg/dl
(14"5 mmol/1)
AST--normal 80
AST--abnormal 80
Uric acid--normal 80
Uric acid--abnormal 80
Total bilirubin--normal 80
Total bilirubin--abnormal 80
Total protein--normal 8O
Total protein--abnormal 80
47 U/1
145 U/1
3"8 mg/dl
(0"23 mmol/1)
7"5 mg/dl
(0"45 rnmol/1)
CV
3"9%
.%
4.8%
3"9%
1.3 mg/dl 5"1%
(22"2 gmol/1)
5"5 mg/dl 5" o
(94"0 [amol/1)
6-2 g/dl 2"0%
(62 g/l)
4.4 g/dl 2"0%
(44 g/l)
The system
The reproducibility of the system for a panel of five tests
was measured using Dade Monitrol ES Level I and
I,evel II Chemistry Controls. A 15-day precision study was
conducted using 12 different Piccolo analysers. A total of
120 rotors were run using each control. The day-to-day
reproducibility is shown in table 1.
A 20-day precision study was conducted by the Scripps
Clinic (LaJolla, CA, USA) using a single Piccolo analyser.
The study was conducted in accordance with the
guidelines published by the National Committee for
Clinical Laboratory Standards. The total imprecision tbr
each method in the rotor is shown in table 2.
Discussion
The precision of metering and mixing plasma and diluent
is better than the2 CV.
It has been demonstrated that a panel ofclinical chemistry
results can be assayed from whole blood using capillary
action and centrifugal force acting from the centre of the
reagent rotor. This meant that a compact analyser
resulting in a portable, convenient system could be
developed. The menu of tests is being expanded and
several different panels will be available.
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